http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a97e932029cdadb97b86bed3231432c8
Outgoing Links
Predicate | Object |
---|---|
family-name | Soehnlein |
name | Oliver Soehnlein |
given-name | Oliver |
organization-name | From the Institute for Cardiovascular Prevention, Ludwig-Maximilians University, Munich, Germany. Department of Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, Johannes Gutenberg University, Staudingerweg 5, DE-55099 Mainz, Germany, and Department of Physiology and Pharmacology, Karolinska Institute, von Eulers väg 8, SE-171 77 Stockholm, Sweden Institute for Cardiovascular Prevention LMU Munich Munich Germany From the Institute for Cardiovascular Prevention (IPEK) (E.K., Z.Z., X.B., M.M.N.S., K.B., O.S., P.v.H., R.T.A.M., A.S., C.W., R.R.K.) and Division of Vascular and Endovascular Surgery (Z.Z., T.A.K.), Ludwig-Maximilians-University Munich, Munich, Germany; Department of Pathology, Academic Medical Center (AMC), Amsterdam, The Netherlands (O.S.); German Centre for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany (O.S., P.v.H., A.S., C.W.); and Department of... 4Institute for Experimental Pathology (ExPat), Center for Molecular Biology of Inflammation, WWU Münster, Münster, Germany.; 5Department of Physiology and Pharmacology (FyFa), Karolinska Institutet, Stockholm, Sweden.; 6Institute for Cardiovascular Prevention (IPEK), LMU Munich Hospital, Munich, Germany. Department of Pathology, Cardiovascular Research Institute Maastricht (CARIM)University Maastricht Maastricht The Netherlands; Institute for Cardiovascular PreventionLudwig‐Maximilians University Munich Germany ¶Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden From the Institute for Molecular Cardiovascular Research (A.Z., Y.D.-T., E.S., K.B., S.M., R.K., C.W.), Institute of Pathology (J.B.), and Medical Clinic III (F.T.), Rheinisch-Westfälische Technische Hochschule, Aachen University, Germany; Division of Biopharmaceutics (I.B., E.A.B.), Gorlaeus Laboratories, Leiden University, The Netherlands; Medical Policlinic (A.S.) and Institute of Physiology (M.S.), Ludwig-Maximilians-University, Munich, Germany; and Department of Physiology (O.S.), Karolinska... Institute for Cardiovascular Prevention (IPEK), Ludwig Maximilian University Munich, Munich Germany.; Academic Medical Center, Amsterdam, Netherlands.; German Centre for Cardiovascular Research, partner site Munich, Munich Germany. Department of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden; Department of Physiology and Pharmacology, Karolinska Institute , Stockholm , Sweden; Institute of Molecular Cardiovascular Research (IMCAR), University Hospital, RWTH Aachen University , Aachen , Germany From the Institute for Cardiovascular Prevention (IPEK) (M.J.S., M. Hilby, K.N., R.G.P., B.F., G.L., O.S., M. Horckmans, C.W., J.D., S.S.), and BioMedical Center, Walter-Brendel-Centre for Experimental Medicine (W.H.), Ludwig-Maximilians-University (LMU), Munich, Germany; Max Delbrueck Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany (K.N.); German Heart Center Munich, Technical University Munich (TUM), Germany (T.K.); Klinikum der Universität München, Medizinische Klinik... Institute for Cardiovascular Prevention, Ludwig Maximilians UniversityMunichGermany; Department of PathologyAcademic Medical CenterAmsterdamThe Netherlands; German Centre for Cardiovascular Research (DZHK)Munich Heart AllianceMunichGermany Institute for Cardiovascular Prevention (IPEK), LMU Munich, Munich, Germany; DZHK, Partner Site Munich Heart Alliance, Munich, Germany; Institute for Experimental Pathology (ExPat), Centre for Molecular Biology of Inflammation (ZMBE), University of Münster, Münster, Germany; Department of Physiology and Pharmacology (FyFa), Karolinska Institutet, Stockholm, Sweden Institute for Cardiovascular Prevention, Ludwig-Maximilians University, Munich, Germany 6; German Centre for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany 9 Institute for Molecular Cardiovascular Research (IMCAR), RWTH University Aachen, Aachen, Germany; and From the Departments of Pathology (C.S.-R., M.D., O.S.) and Biochemistry (C.S.-R., M.d.W., E.L.), Academic Medical Center, Amsterdam, the Netherlands; Institute for Cardiovascular Prevention, Ludwig Maximilian University of Munich, Munich, Germany (C.W., E.L., O.S.); and Deutsches Zentrum für Herz-Kreislauf-Forschung e.V. (DZHK) (German Centre for Cardiovascular Research), partner site of Munich Heart Alliance, Munich, Germany (C.W., O.S.). German Center for Cardiovascular Research, Partner Site Munich, Munich, Germany; Institute for Prevention and Epidemiology of Cardiovascular Diseases, Ludwig-Maximilians-University Munich, Munich, Germany; Department of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden From the Institute for Cardiovascular Prevention (IPEK), Ludwig Maximilians University Munich, Germany (C.W., O.S.); Department of Physiology and Pharmacology (O.S.); German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Germany (O.S., L.M.) Institute for Cardiovascular Prevention, Ludwig-Maximilians University München, Munich 80336, Germany.; Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht 6200, Netherlands.; Institute for Molecular Cardiovascular Research, Interdisciplinary Center for Clinical Research, Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen University, Aachen 52074, Germany. Institute for Cardiovascular Prevention, Ludwig Maximilians University, 80336 Munich, Germany Institute for Cardiovascular Prevention (IPEK), Ludwig Maximilian University, Munich, Germany (O.S.).; Department of Physiology and Pharmacology (FyFa) and Department of Medicine, Karolinska Institutet, Stockholm, Sweden (O.S.).; German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Germany (O.S., C.S.). Institute for Cardiovascular Prevention, Ludwig‐Maximilians‐University, Munich, Germany; Department of Pathology, Academic Medical Center Amsterdam, University of Amsterdam, the Netherlands; Institute for Molecular Cardiovascular Research (IMCAR), RWTH Aachen University, Germany Departments of Physiology and Pharmacology, Karolinska Institutet , Stockholm, Sweden From the Institute for Cardiovascular Prevention (IPEK), Ludwig-Maximilians-University Munich, Munich, Germany (N.G., D.L., H.W., D.P., R.T.A.M., O.S., C.W., E.L.); Department of Medical Biochemistry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands (T.S., H.H., L.B., O.S., E.L.); Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands (M.J.E.K., J.W.M.H., C.W.); Bioceros BV, Utrecht, The... From Institute for Cardiovascular Prevention (Y.D., M.M., B.K., C.N., D.L., M.D., R.T.A.M., M.L., H.H., O.S., C.W.), and Walter Brendel Centre of Experimental Medicine (M.S.), Ludwig-Maximilians University, Munich, Germany; Institute for Molecular Cardiovascular Research, RWTH Aachen University, Aachen, Germany (H.N., P.V.T., W.T.); Center for Nanomedicine, Sanford-Burnham Medical Research Institute, University of California, Santa Barbara, CA (J.D.M.); DZHK (German Centre for Cardiovascular... Department of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden Institute for Cardiovascular Prevention (IPEK), Ludwig Maximilians University, Munich, Germany;; DZHK, Partner Site Munich Heart Alliance, Munich, Germany; and; Department of Pathology, AMC, Amsterdam, The Netherlands Institute for Cardiovascular Prevention, Ludwig Maximilians University Munich, 80336 Munich, Germany.; German Centre for Cardiovascular Research, partner site Munich Heart Alliance, 80336 Munich, Germany.; Department of Pathology, Academic Medical Center, 1105 Amsterdam, Netherlands. From the Institute for Cardiovascular Prevention (IPEK), Ludwig-Maximilians-University, Munich, Germany (M.R., R.G-P., P.R., L.R., M.B., X.B., R.T.A.M., Y.D., O.S., C.W., A.S., S.S.); German Centre for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance (O.S., C.W., S.S.); Department of Physiology and Pharmacology (FyFa), Karolinska Institutet, Stockholm, Sweden (O.S.) From IPEK, LMU Munich, Germany (A.O.-G., J.B., P.L., R.d.J., R.T.A.M., J.J., Y.D., W.S., M.D., C.W., J.G., O.S.); WBex, LMU Munich, Germany (M.S., R.P., C.S., B.W.); Department of Anaesthesiology, University Münster, Germany (J.R., A.Z.); European Vascular Center Aachen-Maastricht, University Hospital RWTH Aachen, Germany (J.T., J.G.); CARIM, Maastricht University, the Netherlands (R.T.A.M., C.W.); DZHK, partner site Munich Heart Alliance, Germany (Y.D., M.D., C.W., O.S.); Department of Medicine,... From the Institute for Cardiovascular Prevention, LMU Munich, Germany; Academic Medical Center, Department of Pathology, Amsterdam University, The Netherlands; and DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Germany. From the Institute for Cardiovascular Prevention, Ludwig Maximilians University Munich, Munich, Germany (Y.D., C.W., O.S.); and Department of Pathology, Academic Medical Center, Amsterdam University, Amsterdam, The Netherlands (O.S.). *Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden; and From the Institute for Cardiovascular Prevention (IPEK), Ludwig-Maximilians-Universität München, Germany (O.S.); Department of Physiology and Pharmacology (FyFa), Karolinska Institutet, Stockholm, Sweden (O.S.); German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Germany (O.S.) DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance , Munich, Germany; Institute for Cardiovascular Prevention (IPEK), Ludwig Maximilians University Munich , Munich, Germany; Department of Physiology and Pharmacology (FyFa), Karolinska Institute , Stockholm, Sweden; Institute for Experimental Pathology, University of Münster , Münster, Germany From the Division of Cardiology, University Hospital, Geneva, Switzerland (S.L., F.M., F.B., G.P., K.G., S.S.); Unit of Toxicology, University Center of Legal Medicine, Geneva, Switzerland (A.T., C.S.); Institute for Cardiovascular Prevention, Ludwig-Maximilians-University Munich, Munich, Germany (O.S.); Department of Pathology, Academic Medical Center, Amsterdam, The Netherlands (O.S.); First Clinic of Internal Medicine, Department of Internal Medicine, University of Genoa, Genoa, Italy (F.M.); and... Institute of Cardiovascular Prevention, Department of Medicine, Ludwig-Maximilians-University Munich, Germany (Y.D., O.S.); German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Germany (Y.D., O.S.); Department of Physiology and Pharmacology (FyFA), Karolinska Institute, Stockholm, Sweden (O.S.). DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance , Munich , Germany; Institute for Cardiovascular Prevention (IPEK), Ludwig Maximilian University of Munich , Munich , Germany; Department of Physiology and Pharmacology (FyFa), Karolinska Institute , Stockholm , Sweden Faculty of Medicine Institute for Cardiovascular Prevention Ludwig‐Maximilians‐University Munich Germany From the Institute for Cardiovascular Prevention, LMU Munich, Germany; Academic Medical Center, Department of Pathology, Amsterdam University, The Netherlands; and DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany. Institute for Cardiovascular Prevention, Ludwig Maximilian University of Munich, Munich, Germany;; German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Munich, Germany; and; Academic Medical Center, Department of Pathology, Amsterdam University, The Netherlands Institute for Cardiovascular Prevention, Ludwig-Maximilians-University Munich, Munich, Germany;; Department of Pathology, Academic Medical Center of the University of Amsterdam, Amsterdam, The Netherlands; and; German Centre for Cardiovascular Research, Partner Site Munich Heart Alliance, Munich, Germany From the Institute for Cardiovascular Prevention (IPEK), LMU Munich, Germany (J.R.V., P.L., Y.J., C.W., C.N., C.S.-R., Y.D., M.D., C.W., O.S.); Department of Pathology, Academic Medical Center (AMC), Amsterdam University, The Netherlands (J.R.V., C.S.-R., M.D., O.S.); Department of Informatics, Institute of Bioinformatics, LMU Munich, Germany (G.C., R.Z.); DZHK, Partner Site Munich Heart Alliance, Germany (C.W., Y.D., M.D., C.W., O.S.); Mass Spectrometry Core Facility, Max-Delbrück Center, Berlin... Institute for Cardiovascular Prevention (R.T.A.M., C.S.-R., Q.B., O.S.), Ludwig-Maximilians-University, Munich, Germany; German Center for Cardiovascular Research, Partner Site Munich Heart Alliance (O.S., J.B.); Department of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden (O.S.). From the IPEK, LMU, Munich, Germany (S.W., J.-E.A., R.T.A.M., Y.D., M.D., P.v.H., C.W., O.S.); IMCAR, RWTH Aachen, Germany (S.W.); Department of Physiology, Karolinska Institutet, Stockholm, Sweden (A.M.v.d.D., L.L.); Department of Medicine, Washington University, St Louis, MO (C.T.N.P.); National Center for Drug Screening, Shanghai, China (M.-W.W.); Laboratory of Molecular Immunoregulation, NCI, Frederick, MD (J.-M.W.); Department of Medicine, University of California at San Diego, La Jolla, CA (R... From the Institute for Cardiovascular Prevention, Ludwig-Maximilians-University Munich, Munich (Y.D., O.S., M.D., H.H., M.H., R.R.K., C.W.); Institute for Biomedical Engineering, Department of Cell Biology, RWTH Aachen University (Y.D., T.H., M.Z.); Institute for Molecular Cardiovascular Research, University Hospital Aachen, Aachen (O.S., E.S., S.M., H.H., A.Z.); Rudolf-Virchow-Center/DFG Research Center for Experimental Biomedicine, University of Würzburg, Würzburg, Germany (M.D., S.M.C., A.Z.);... From the Institute for Cardiovascular Prevention, Department of Medicine, Ludwig-Maximilians-University (LMU) Munich, Germany (S.S., C. Winter, M.J.S., A.H., C. Weber, O.S.); German Center for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Germany (S.S., C. Weber, O.S.); Fundación Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain (A.H.); Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, the Netherlands (C. Weber); and Department... LUDWIG MAXIMILIAN UNIVERSITY OF MUNICH; AMSTERDAM UNIVERSITY; GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH Institute for Experimental Pathology (ExPat), Center for Molecular Biology of Inflammation (ZMBE), University of Münster , Von-Esmarch-Straße 56, 48149, Münster , Germany; Department of Physiology and Pharmacology (FyFa), Karolinska Institute , Solnavägen 1, 171 77, Stockholm , Sweden Institute for Cardiovascular Prevention (IPEK), Ludwig-Maximilians-Universität München, Pettenkofer Straße 8a, 80336 Munich, Germany; Department of Physiology and Pharmacology (FyFa), Karolinska Institutet, Solnavägen 1, 17177 Stockholm, Sweden; Institute for Experimental Pathology (ExPat), Center for Molecular Biology of Inflammation (ZMBE), Westfälische Wilhelms-Universität Münster, Von-Enmarch-Straße 56, 48149 Münster, Germany Institute for Molecular Cardiovascular Research,; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden; From the Institute for Molecular Cardiovascular Research (M.D., R.T.A.M., M.v.Z., C.W., O.S.) and Interdisciplinary Centre for Clinical Research (R.T.A.M.), RWTH Aachen University, Aachen, Germany; Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität, Munich, Germany (C.W.); and Cardiovascular Research Institute Maastricht, University of Maastricht, Maastricht, the Netherlands (M.v.Z., C.W.). Institute of Experimental Pathology, Center for Molecular Biology of Inflammation (ZMBE), University of Münster, 48149 Münster, Germany; Department of Physiology and Pharmacology (FyFa), Karolinska Institute, 171 77 Stockholm, Sweden; Institute for Cardiovascular Prevention (IPEK), LMU Munich, 80336 Munich, Germany From the Institute for Molecular Cardiovascular Research (S.F.M., E.R., E.A.L., M.H., K.B., O.S., C.W.), Department of Cardiology (S.F.M., E.A.L.), and Institute for Biochemistry and Molecular Biology (G.M.-N.), Medical Faculty, RWTH Aachen University, Aachen, Germany. From Experimental Vascular Pathology Group, Department of Pathology, CARIM, Maastricht University Medical Center, The Netherlands (I.M., J.S., I.W., V.H., M.G., J.C., E.A.L.B.); Division of Biopharmaceutics, Leiden Academic Center for Drug Research, Leiden University, The Netherlands (I.M., I.B., S.C.A.d.J., T.J.C.v.B.); CNRS, IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France (C.C., I.M.-P.); Université de Toulouse, France (C.C., I.M.-P.); Institute for Prevention of... From the Institute for Cardiovascular Prevention (Y.D., M.D., S.W., K.K., D.L., C.W., O.S.), Ludwig-Maximilians University München, Munich, Germany; Institute for Molecular Cardiovascular Research (S.W., S.V.), Rheinisch-Westfälische Technische Hochschule Aachen University, Aachen, Germany; Department of Medicine (R.L.G.), University of California at San Diego, La Jolla, CA. Institute for Cardiovascular Prevention, Ludwig Maximilian University Munich, Munich, Germany;; Department of Pathology, Academic Medical Center, Amsterdam, The Netherlands;; German Centre for Cardiovascular Research, Partner Site Munich Heart Alliance, Munich, Germany Institute for Cardiovascular Prevention (IPEK), LMU München , Munich, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Munich, Heart Alliance Munich , Munich, Germany; Institute for Experimental Pathology (ExPat), Center for Molecular Biology of Inflammation (ZMBE) , Von-Esmarch-Straße 56, WWU Münster 48149, Germany Institute for Cardiovascular Prevention (IPEK), LMU Munich Hospital, Pettenkoferstrasse 8a, D-80336 Munich, German y; Institute for Experimental Pathology (ExPat), Center for Molecular Biology of Inflammation, WWU Münster, Von-Esmarch-Strasse 56 48149 Münster, German y; Department of Physiology and Pharmacology (FyFa), Karolinska Institutet, Stockholm, Sweden Institute for Cardiovascular Prevention (IPEK), LMU Munich, Germany (N.P., J.R.V., S.L.M., R.d.J., C.W., M.D., Y.D., O.S.).; DZHK, partner site Munich Heart Alliance, Germany (N.P., J.R.V., C.W., M.D., Y.D., O.S.).; Department of Physiology and Pharmacology (FyFa), Karolinska Institutet, Stockholm, Sweden (O.S.). From the Institute for Cardiovascular Prevention (IPEK), Department of Medicine, LMU Munich, Germany (Y.D., O.S., C.W.); DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Germany (O.S., C.W.); Department of Pathology, Academic Medical Center, Amsterdam, The Netherlands (O.S.); and Department of Biochemistry, Cardiovascular Research Institute (CARIM), Maastricht University, The Netherlands (C.W.). Institute for Cardiovascular Prevention (IPEK), Ludwig-Maximilians-Universität München, Munich, Germany.; German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany.; Department of Physiology and Pharmacology, Karolinksa Institutet, Stockholm, Sweden. From the Institute for Cardiovascular Prevention (D.P., D.L., B.K.K., O.S., C.W., R.R.K.), Ludwig-Maximilians-University of Munich; Institute for Molecular Cardiovascular Research (O.P., E.M.V., D.P., E.A.L., W.T.), and the Institute of Pharmacology and Toxicology (A.L.), RWTH Aachen University, Aachen, Germany; Vesalius Research Center (S.C.), Flanders Institute for Biotechnology (VIB), Catholic University Leuven, Leuven, Belgium; Institute of Cellular Biology and Pathology ‘Nicolae Simionescu’ (E... Institute for Cardiovascular Prevention (IPEK), Ludwig-Maximilians-University of Munich , Munich , Germany; Department of Physiology and Pharmacology (FyFa), Karolinska Institutet , Stockholm , Sweden; Institute for Experimental Pathology (ExPat), Center for Molecular Biology of Inflammation (ZMBE), Westfaelische Wilhelms-University of Muenster , Muenster , Germany From Institute for Cardiovascular Prevention, Ludwig-Maximilians-University Munich, Germany (Y.D., O.S., C.W.); Academic Medical Center, Department of Pathology, Amsterdam University, the Netherlands (O.S.); and DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Germany (O.S., C.W.). Institute for Cardiovascular Prevention, Ludwig Maximilians University Munich, 80336 Munich, Germany; German Centre for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, 80336 Munich, Germany; Department of Pathology, Academic Medical Center (AMC), University of Amsterdam, 1105 AZ Amsterdam, The Netherlands Institute for Molecular Cardiovascular Research and; Institute for Cardiovascular Prevention, Ludwig-Maximilians-University, Munich, Germany; Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands Institute for Cardiovascular Prevention (IPEK), LMU Munich, Germany; Department of Physiology and Pharmacology (FyFa) & Department of Medicine, Karolinska Institutet, Stockholm, Sweden; German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany Institute for Cardiovascular Prevention, LMU Munich, Munich, Germany; Department of Pathology, Academic Medical Center, Amsterdam University, The Netherlands; DZHK, Partner Site Munich Heart Alliance, Munich, Germany; Department of Physiology and Pharmacology (FyFa), Karolinska Institutet, Stockholm, Sweden; Department of Medicine, Karolinska Institutet, Stockholm, Sweden From the Department of Physiology and Pharmacology (E.L., A.M.V.D.D., E.K., L.L.) and Department of Molecular Medicine and Surgery, Center of Molecular Medicine (E.K.), Karolinska Institutet, Stockholm, Sweden; Institute for Cardiovascular Prevention, Ludwig-Maximilians University, Munich, Germany (O.S.); Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands (O.S.); and German Centre for Cardiovascular Research (DZHK), Partner Site Munich Heart... Institute for Cardiovascular Prevention, LMU Munich, Munich, Germany; DZHK, Partner site Munich Heart Alliance, Munich, Germany; Department of Physiology and Pharmacology (FyFa), Karolinska Institutet, Stockholm, Sweden Institute for Cardiovascular Prevention, Ludwig-Maximilians-University Munich, Pettenkoferstr. 9, 80336, Munich, Germany. oliver.soehnlein@gmail.com. Department of Pathology, Academic Medical Center, Amsterdam University, Amsterdam, The Netherlands. oliver.soehnlein@gmail.com. DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany. oliver.soehnlein@gmail.com. From the Institute for Cardiovascular Prevention, Ludwig-Maximilians-University Munich, Munich, Germany (Y.D., M.D., O.S., C.W.); Department of Pathology, Academic Medical Center, Amsterdam University, Amsterdam, The Netherlands (M.D., O.S.); and German Centre for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany (O.S., C.W.). Institute for Cardiovascular Prevention (IPEK), LMU Munich, Munich, Germany; DZHK, Partner Site Munich Heart Alliance, Munich, Germany; Department of Physiology and Pharmacology (FyFa), Karolinska Institutet, Stockholm, Sweden; Department of Medicine, Karolinska Institutet, Stockholm, Sweden Institute for Cardiovascular Prevention, Ludwig-Maximilians-University, Munich, Germany (C.S.-R., A.H., O.S.); Department of Physiology and Pharmacology (FyFa), Karolinska Institutet, Stockholm, Sweden (O.S.); German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany (O.S.). Institute for Cardiovascular Prevention, Klinikum LMU Munich, Germany (O.S.); German Center for Cardiovascular Research, Partner Site Munich Heart Alliance (O.S.); Department of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden (O.S.) Institute for Molecular Cardiovascular Research, RWTH Aachen University, Aachen 52074, Germany 3 From the Institute for Cardiovascular Prevention (IPEK), LMU Munich, Germany (E.P.C.v.d.V., M. Mandl, M. Müller, C.N., Y.J., M.H., S.G., L.J.F.P., S.M., O.S., M.D., C.W., Y.D.); DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Germany (E.P.C.v.d.V., O.S., C.W., Y.D.); Department of Physiology and Pharmacology (FyFa), Karolinska Institutet, Stockholm, Sweden (O.S.). Institute for Cardiovascular Prevention (IPEK), Ludwig-Maximilians Universität, München, Germany;; German Centre for Cardiovascular Research (DZHK), Munich Heart Alliance, Munich, Germany; and; Department of Pathology, Amsterdam Medical Center, Amsterdam, The Netherlands DZHK (German Center for Cardiovascular Research) Partner Site Munich Heart Alliance Munich Germany; Institute for Cardiovascular Prevention Ludwigs‐Maximilians‐University Munich Germany; Institute for Experimental Pathology (ExPat) Center for Molecular Biology of Inflammation (ZMBE) WWU Münster Germany Institute for Cardiovascular PreventionLudwig-Maximilians-University (LMU) Munich Germany; Karolinska Institutet Stockholm Sweden; German Center for Cardiovascular research (DZHK)Partner Site Munich Heart Alliance (MHA) Berlin Germany From the IPEK, LMU Munich, Germany (R.J.d.J., N.P., P.L., J.R.V., C. Winter, B.F., J.G., C. Weber, M.D., O.S.); Department of Pathology, AMC, Amsterdam University, The Netherlands (R.J.d.J., J.R.V., M.D., O.S.); Department of Experimental Medicine, Second University of Naples, Italy (B.F.); European Vascular Center Aachen-Maastricht, University Hospital RWTH Aachen, Germany (J.G.); Department of Biochemistry, CARIM, Maastricht University, The Netherlands (C. Weber, C.R.); and DZHK, partner site... Department of Physiology and PharmacologyKarolinska InstitutetStockholmSweden Institute of Cardiovascular Prevention, LMU Munich, Munich, Germany;; German Center for Cardiovascular Research, Partner Site Munich Heart Alliance, Munich, Germany; and; Department of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden Department of Physiology and PharmacologyKarolinska Instituted Stockholm Sweden; Institute for Cardiovascular PreventionLudwig Maximilian University of Munich Munich Germany; Partner Site Munich Heart AllianceGerman Centre for Cardiovascular Research (DZHK) Berlin Germany DZHK (German Center for Cardiovascular Research), partner site Munich Heart Alliance, Germany (A.B., V.J., K.K., T.B., N.H., B.F., O.S., K.L.L., R.H., C.K.).; Institute for Cardiovascular Prevention (B.F., O.S.), LMU Munich, Germany. From the Institute for Cardiovascular Prevention, Ludwig-Maximilians-University, Munich, Germany (M.D., J.D., O.S.); Department of Pathology, Academic Medical Center Amsterdam, University of Amsterdam, Amsterdam, The Netherlands (M.D., O.S.); and German Centre for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany (M.D., O.S.). Institute for Cardiovascular Prevention, Ludwig Maximilian University Munich, Munich, Germany From the Institute for Cardiovascular Prevention, Ludwig-Maximilians-University Munich, Munich, Germany (Y.D., M.D., D.L., R.T.A.M., O.S., R.R.K., E.L., C.W.); Institute for Biomedical Engineering, Department of Cell Biology, RWTH Aachen University, Aachen, Germany (Y.D., M.Z.); Rudolf Virchow Center, DFG Research Center for Experimental Medicine, University of Würzburg, Würzburg, Germany (H.D.M., M.B., A.Z.); Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, the... Institute for Cardiovascular Prevention (IPEK), Ludwig Maximilians University, Munich, Germany (C. Winter, C. Weber, L.M., O.S.); German Centre of Cardiovascular Research (DZHK), Berlin-Wedding, Germany (R.A.B., C. Weber, O.S., A.Z., S.D.); Department of Physiology and Pharmacology (FyFa), Karolinska Institutet, Stockholm, Sweden (O.S.). Institute for Molecular Cardiovascular Research, Rheinisch-Westfälische Technische Hochschule Aachen University, Aachen, Germany; Institute for Cardiovascular Prevention, Ludwig‐Maximilians University Munich, Munich, Germany From the Institute for Cardiovascular Prevention (IPEK), LMU Munich, Munich, Germany (M.D., R.d.J., J.R.V., G.L., J.G., C.W., Y.D., O.S.); Department of Pathology, Academic Medical Center (AMC), Amsterdam University, Amsterdam, The Netherlands (M.D., O.S.); Department of Anaesthesiology, University Münster, Münster, Germany (J.R., A.Z.); Max Planck Institute, Münster, Germany (J.R., A.Z.); Laboratory of Molecular Immunoregulation, NCI, Frederick, MD (J.M.W.); European Vascular Center Aachen... From the Department of Epidemiology, Atherothrombosis, and Imaging, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain (R.C., J.M.G.-G., V.S., C.S.-R., P.M.-S., A.H., V.A.); Institute for Cardiovascular Prevention, Ludwig-Maximilians-University Munich and DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany (R.T.A.M., C.W., O.S.); Cardiovascular Research Institute Maastricht, Maastricht, The Netherlands (R.T.A.M., C.W.); and Academic... Institute for Cardiovascular Prevention (IPEK) Ludwig‐Maximilians‐University (LMU) Munich Munich Germany; German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance Munich Germany; Department of Pathology Amsterdam Medical Center (AMC) Amsterdam The Netherlands Institute for Cardiovascular Prevention, Ludwig-Maximilians University, Munich, Germany; Department of Pathology, Academic Medical Center, Amsterdam University, Amsterdam, the Netherlands; DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany |
Incoming Links
Total number of triples: 290.